2 drug(s) with this reaction
9,543 total reports
Pemphigus has been reported as an adverse reaction across 2 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 9,543 adverse event reports mention pemphigus in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with pemphigus, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have pemphigus listed in their FDA adverse event reports, sorted by report count:
In addition to pemphigus, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
2 drug(s) manufactured by Haleon Us Holdings Llc have pemphigus listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE.
There are a combined 9,543 reports of pemphigus across 2 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.